Pharma Cos. Can't Dodge Lidoderm Buyers' Antitrust MDL
A California federal judge Friday squashed attempts by pharmaceutical companies Endo, Teikoku and Watson to end multidistrict antitrust litigation over the Lidoderm pain patch, ruling that there's enough evidence to show...To view the full article, register now.
Already a subscriber? Click here to view full article